Cara therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Cara therapeutics Contact Number

Contact – Cara Therapeutics

1 hours ago Caratherapeutics.com Show details

203-406-3700

Cara Therapeutics 4 Stamford Plaza 107 Elm Street, 9th floor Stamford, CT 06902. 1-203-406-3700

1. 107 Elm St, Stamford, CT 06902 · (203) 406-3700DIRECTIONSWEBSITE

Category: Contact SupportShow more

Contact Us Cara Therapeutics

2 hours ago Ir.caratherapeutics.com Show details

The Investor Relations website contains information about Cara Therapeutics's business for stockholders, potential investors, and financial analysts.

Category: Contact SupportShow more

Cara Therapeutics Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

Contact Email [email protected]caratherapeutics.com. Phone Number 2035671503. Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first

Founders: Derek Chalmers, Michael E. Lewis

Category: Contact NumberShow more

Cara Therapeutics

3 hours ago Caratherapeutics.com Show details

Cara Therapeutics is a close-knit group of scientists, medical experts, and industry leaders deeply committed to the science of changing lives. Our proprietary, novel therapies have the potential to make a significant impact for the millions of pruritus sufferers who have been overlooked.

Category: Contact NumberShow more

Cara Care Crunchbase Company Profile & Funding

4 hours ago Crunchbase.com Show details

49 30 3080

Contact Email [email protected]cara.care. Phone Number 49 30 30809546. Cara by HiDoc Technologies is an pharmaceutical company that empowers patients suffering from chronic digestive diseases. At Cara Care they develop companion digital therapeutics to enhance state of the art therapies for GI diseases. Founded in 2015, Cara is based in Berlin, Berlin

Founders: Andre Sommer, Orest Tarasiuk, Dankrad Feist, Jesaja Brinkmann

Category: Contact NumberShow more

Cara Therapeutics Profile GetCompanyInfo

7 hours ago Getcompanyinfo.com Show details

About Cara Therapeutics. Cara Therapeutics was incorporated in 2004 and is located in Stamford, United States. The company specialises in Develops Therapeutics, Human Diseases with an estimated revenue of More than $10,000 million and employee in the range of 51-200 respectively.

Category: Contact NumberShow more

Management Team Bios – Cara Therapeutics

4 hours ago Caratherapeutics.com Show details

Dr. Goncalves brings more than 17 years of leadership experience in the biopharmaceutical industry to Cara. Most recently, she served as Vice President, Medical Affairs for Dermatology and Neurology at Celgene Corporation where she was instrumental in planning and executing medical support activities for a number of programs, including OTEZLA ® for psoriasis.

Category: Contact NumberShow more

Cara Therapeutics Reports First Quarter 2021 Financial

9 hours ago Ir.caratherapeutics.com Show details

212-362-1200

INVESTOR CONTACT: Janhavi Mohite Stern Investor Relations, Inc. 212-362-1200 [email protected] MEDIA CONTACT: Claire LaCagnina 6 Degrees 315-765-1462 [email protected] Source: Cara Therapeutics, Inc.

Category: Contact NumberShow more

CARA Cara Therapeutics Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

"The FDA approval of KORSUVA™ injection is a transformational milestone for Cara and a significant advancement for the substantial number of adult hemodialysis patients suffering from moderate-to-severe pruritus," said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara Therapeutics.

Category: Contact NumberShow more

Vifor Pharma and Cara Therapeutics announce U.S. FDA

3 hours ago Dkoding.in Show details

“The FDA approval of KORSUVA™ injection is a transformational milestone for Cara and a significant advancement for the substantial number of adult hemodialysis patients suffering from moderate-to-severe pruritus,” said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara Therapeutics.

Category: Contact NumberShow more

Cara Therapeutics The Branford Group

7 hours ago Thebranfordgroup.com Show details

Cara Therapeutics – Lot Catalog. Lot Closings: Lot Closings: The Lots will have a staggered closing time with 1 closing every minute in numerical order. For Example: Lot 1 will start to close at 10:00 AM, Lot 2 will start to close at 10:01 AM and so forth. (On the day the auction is set to close, each lot will clearly countdown the time left until closing.)

Category: Contact NumberShow more

Cara Therapeutics and Vifor Pharma announce U.S. FDA

1 hours ago Globenewswire.com Show details

315-765-1462

Media Contact Claire LaCagnina 6 Degrees 315-765-1462 [email protected] : Investor Contact Janhavi Mohite Stern Investor Relations, Inc. 212-363-1200

Category: Contact NumberShow more

Cara Therapeutics, inc (CARA) Q2 2021 Earnings Call

9 hours ago Fool.com Show details

Cara Therapeutics, inc (CARA) Q2 2021 Earnings Call Transcript CARA earnings call for the period ending June 30, 2021.

Category: Contact NumberShow more

Study to Evaluate the Safety and Efficacy of Oral CR845

1 hours ago Clinicaltrials.gov Show details

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03995212

Category: Contact NumberShow more

VFMCRP and Cara Therapeutics announce European Medicines

Just Now Ir.caratherapeutics.com Show details

315-765-1462

Cara Therapeutics contacts: Media Contact Claire LaCagnina 6 Degrees 315-765-1462 [email protected] Investor Contact Janhavi Mohite Stern Investor Relations, Inc. 212-363-1200 [email protected]

Category: Contact NumberShow more

Cara Therapeutics Employees, Board Members, Advisors

4 hours ago Crunchbase.com Show details

Cara Therapeutics has 5 current employee profiles, including Co-founder, Chief Executive Officer, President & Director Derek Chalmers. Cara Therapeutics has 3 board members and advisors, including Geoffrey W. Smith.

Category: Contact NumberShow more

Cara Therapeutics Announces Topline Results From KARE

8 hours ago Ir.caratherapeutics.com Show details

315-765-1462

Except to the extent required by law, Cara Therapeutics undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. MEDIA CONTACT: Claire LaCagnina 6 Degrees 315-765-1462 [email protected] INVESTOR CONTACT: Janhavi Mohite Stern Investor Relations, Inc.

Category: Contact NumberShow more

Cara Therapeutics Number of Employees 20122021 CARA

4 hours ago Macrotrends.net Show details

Cara Therapeutics number of employees from 2012 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Cara Therapeutics and Vifor Pharma announce U.S. FDA

8 hours ago Ir.caratherapeutics.com Show details

About Cara Therapeutics Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. Cara is developing a novel and proprietary class of product candidates, led by KORSUVA™ (CR845/difelikefalin), a first-in-class KOR …

Category: Contact NumberShow more

Cara Therapeutics The Branford Group

9 hours ago Thebranfordgroup.com Show details

Cara Therapeutics – Lot Catalog. Lot Closings: Lot Closings: The Lots will have a staggered closing time with 1 closing every minute in numerical order. For Example: Lot 1 will start to close at 10:00 AM, Lot 2 will start to close at 10:01 AM and so forth. (On the day the auction is set to close, each lot will clearly countdown the time left until closing.)

Category: Contact NumberShow more

CARA THERAPEUTICS, INC. : Shareholders Board Members

2 hours ago Marketscreener.com Show details

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the …

Category: Contact NumberShow more

Cara Therapeutics And IV Korsuva: Key Bull And Bear

2 hours ago Seekingalpha.com Show details

Cara Therapeutics' IV Korsuva for the treatment of severe itching (pruritus) in CKD patients on dialysis has a PDUFA date of August 23, 2021. Read our key bull and bear thoughts.

Category: Contact NumberShow more

Joana Goncalves Net Worth, Biography & Insider Trading History

4 hours ago Insidertrades.com Show details

(203) 406-3700

The corporate mailing address for Dr. Goncalves and other Cara Therapeutics executives is 107 ELM STREET 9TH FLOOR, STAMFORD CT, 06902. Cara Therapeutics can also be reached via phone at (203) 406-3700 and via email at [email protected]

Category: Contact NumberShow more

Why Cara Therapeutics Shot Higher Today The Motley Fool

2 hours ago Fool.com Show details

Cara Therapeutics ( NASDAQ:CARA) was a hot stock on Tuesday. One of the formerly clinical-stage biotech's drug candidates won FDA approval, and …

Category: Contact NumberShow more

Cara Therapeutics Presents LateBreaking Results of KARE

6 hours ago Globenewswire.com Show details

Risks are described more fully in Cara Therapeutics’s filings with the Securities and Exchange Commission, including the "Risk Factors" section of Cara

Category: Contact NumberShow more

Cara Therapeutics Nothing seems to bother Stock market

1 hours ago Stockmarketdaily.co Show details

Cara Therapeutics, Inc. is expected* to report earnings on 02/25/2021 after market close. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.53. The reported EPS for the same quarter last year was $-0.61.

Category: Contact NumberShow more

Cara Therapeutics Inc AnnualReports.com

9 hours ago Annualreports.com Show details

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase 2 clinical trials for the treatment acute postoperative pain

Category: Contact NumberShow more

Cara Therapeutics Inc (CARA) has fallen 9.70% in a Week

Just Now Investorsobserver.com Show details

Cara Therapeutics Inc is near the top in its industry group according to InvestorsObserver.CARA gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Cara Therapeutics Inc gets a 91 rank in the Biotechnology industry. Biotechnology is number 80 out of 148 industries.

Category: Contact NumberShow more

BLACKROCK INC. SC 13G/A Filing Concerning CARA on 20210430

8 hours ago Whalewisdom.com Show details

us1407551092_050621.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) CARA THERAPEUTICS INC ----- (Name of Issuer) Common Stock ----- (Title of Class of Securities) 140755109 ----- (CUSIP Number) April 30, 2021 ----- (Date of Event Which Requires Filing of this Statement) …

Category: Contact NumberShow more

Cara Therapeutics Reports First Quarter 2021 Financial Results

5 hours ago Finance.yahoo.com Show details

Cara management will host a conference call today at 4:30 p.m. ET to discuss first quarter 2021 financial results and provide a business update. …

Category: Contact NumberShow more

Thomas Charles Reilly Net Worth, Biography & Insider

Just Now Insidertrades.com Show details

(203) 406-3700

The corporate mailing address for Mr. Reilly and other Cara Therapeutics executives is 107 ELM STREET 9TH FLOOR, STAMFORD CT, 06902. Cara Therapeutics can also be reached via phone at (203) 406-3700 and via email at [email protected]

Email: [email protected]
Phone: (203) 406-3700
Occupation: CFO, Cara Therapeutics

Category: Contact NumberShow more

Frederique Ph.D. Menzaghi Net Worth, Biography & Insider

2 hours ago Insidertrades.com Show details

Dr. Frederique Menzaghi is one of the founders of Cara Therapeutics, a provider of novel drugs for the treatment of human diseases associated with pain and inflammation. Dr. Menzaghi has also been serving as Cara’s chief scientific officer since 2019, and its senior vice president of research and development since 2017.. Dr. Menzaghi leads preclinical research and pruritus clinical …

Category: Contact NumberShow more

A Study to Evaluate the Safety and Efficacy of CR845 in

7 hours ago Clinicaltrials.gov Show details

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03422653

Category: Contact NumberShow more

Cara Therapeutics, Inc. DEF 14A Apr. 22, 2020 4:30 PM

9 hours ago Seekingalpha.com Show details

Corporate Secretary. April 22, 2020. A copy of the Company’s Annual Report to the Securities and Exchange Commission on Form 10-K for the fiscal year ended December 31, 2019 is available without

Category: Contact NumberShow more

CARA THERAPEUTICS, INC. : CARA Stock Price US1407551092

4 hours ago Marketscreener.com Show details

84,4%. Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that …

Category: Contact NumberShow more

Cara Therapeutics (NASDAQ:CARA) Valuation Analysis Macroaxis

8 hours ago Macroaxis.com Show details

Cara Therapeutics shows a prevailing Real Value of $19.03 per share. The current price of the firm is $15.25. At this time, the firm appears to be undervalued.Our model approximates the value of Cara Therapeutics from analyzing the firm fundamentals such as Current Valuation of 447.81 M, profit margin of 6.23 %, and Return On Equity of 3.86 % as well as examining its technical indicators and

Category: Contact NumberShow more

Cara Therapeutics, Inc. Common Stock (CARA) Institutional

3 hours ago Nasdaq.com Show details

06/30/2021. 432,178. -294,405. -40.519%. $5,687. Back to CARA Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange

Category: Contact NumberShow more

News Flash: 8 Analysts Think Cara Therapeutics, Inc

3 hours ago Finance.yahoo.com Show details

See our latest analysis for Cara Therapeutics earnings-and-revenue-growth The consensus price target fell 5.5% to US$26.11, with the analysts …

Category: Contact NumberShow more

Martin Vogelbaum Net Worth, Biography & Insider Trading

5 hours ago Insidertrades.com Show details

(203) 406-3700

The corporate mailing address for Mr. Vogelbaum and other Cara Therapeutics executives is 107 ELM STREET 9TH FLOOR, STAMFORD CT, 06902. Cara Therapeutics can also be reached via phone at (203) 406-3700 and via email at [email protected]

Category: Contact NumberShow more

Why Is Cara Therapeutics Stock Trading Higher Today?

1 hours ago Finance.yahoo.com Show details

Cara Therapeutics Inc (NASDAQ: CARA) is trading higher Tuesday after the company, and Vifor Pharma, announced the U.S. Food and Drug Administration approved KORSUVA for injection for the treatment

1. Author: Adam Eckert

Category: Contact NumberShow more

Vifor Pharma : and Cara Therapeutics announce U.S. FDA

8 hours ago Marketscreener.com Show details

'The FDA approval of KORSUVA™ injection is a transformational milestone for Cara and a significant advancement for the substantial number of adult hemodialysis patients suffering from moderate-to-severe pruritus,' said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara Therapeutics.

Category: Contact NumberShow more

Were Hedge Funds Right About Cara Therapeutics Inc (CARA)?

Just Now Finance.yahoo.com Show details

Cara Therapeutics Inc (NASDAQ: CARA) was in 17 hedge funds' portfolios at the end of March. The all time high for this statistic is 19. CARA investors …

Category: Contact NumberShow more

Statement of Changes in Beneficial Ownership (4)

Just Now Ih.advfn.com Show details

Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which

Category: Contact NumberShow more

Cara Therapeutics Target Price CARA

3 hours ago Macroaxis.com Show details

Cara Therapeutics' current and average target prices are 14.67 and 25.88, respectively. The current price of Cara Therapeutics is the price at which Cara Therapeutics is currently trading. On the other hand, Cara Therapeutics' target price is what analysts think the stock is …

Category: Contact NumberShow more

Postoperative Pain Market to Rising Steadily at a 7.93%

7 hours ago Finance.yahoo.com Show details

Postoperative Pain Market to Rising Steadily at a 7.93% CAGR Owing to Growing Number of Surgeries, During the Study Period [2018-2030], Says DelveInsight Read full …

Category: Contact NumberShow more

Cara Therapeutics Inc (CARA) is lower by 1.61% Thursday In

5 hours ago Investorsobserver.com Show details

In the Biotechnology industry which is number 135 by this metric, CARA ranks better than 37% of stocks. Important Dates for Investors in CARA:-Cara Therapeutics Inc is set to release earnings on 11/8/2021. During their last earnings release the company posted EPS of $0.26. -We do not have a set dividend date for Cara Therapeutics Inc at this time.

Category: Contact NumberShow more

Cara, Vifor receive FDA nod for Korsuva Drug Store News

4 hours ago Drugstorenews.com Show details

Cara, Vifor receive FDA nod for Korsuva. Korsuva for injection is a kappa-opioid receptor agonist that targets the body’s peripheral nervous system. Cara Therapeutics and Vifor Pharma have

Category: Contact NumberShow more

CARA Forecast Dividend Channel

3 hours ago Dividendchannel.com Show details

021-09-28

Meanwhile, note that the median CARA forecast price target (median being the middle where half of analysts had a higher CARA forecast and half had a lower CARA forecast, which is a different metric than the average or mean) was $27.0 as of 2021-09-28, while the highest CARA forecast in the analyst group was $35.0, and the lowest CARA forecast

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae